Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids

Oncology Reports

Volumn 32, Issue 2, 2014, Pages 641-649

  Oktem, Gulperi ^a   Sercan, O ^b   Guven, U ^a   Uslu, R ^a   Uysal, A ^a   Goksel, G ^c   Ayla, S ^d   Bilir, A ^e  

^a EGE UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c CELAL BAYAR UNIVERSITY   (Turkey)

^d Zeynep Kamil Gynecology and Pediatrics Training and Research Hospital   (Turkey)

^e ZIRVE UNIVERSITY   (Turkey)

Author keywords

Adhesion molecules; Cancer stem cells; Spheroid; Tgf 1; Versican

Indexed keywords

BETA3 INTEGRIN; COLLAGEN TYPE 7; COLLAGEN TYPE 7A1; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE 1; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; VERSICAN; CD133 ANTIGEN; CD44 PROTEIN, HUMAN; COL7A1 PROTEIN, HUMAN; GLYCOPROTEIN; HERMES ANTIGEN; ITGB3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PEPTIDE; TGFB1 PROTEIN, HUMAN; TUMOR MARKER; VCAN PROTEIN, HUMAN;

ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CDH1 GENE; CELL DIFFERENTIATION; CELL PROLIFERATION; COL7A1 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MMP1 GENE; MMP16 GENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TGF BETA1 GENE; TUMOR GROWTH; TUMOR SPHEROID; UPREGULATION; VCAN GENE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANTIGENS, CD; ANTIGENS, CD44; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLLAGEN TYPE VII; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; INTEGRIN BETA3; MALE; NEOPLASTIC STEM CELLS; PEPTIDES; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; VERSICANS;

EID: 84903182903     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3252     Document Type: Article

References (35)

1. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003. (Pubitemid 37187480)
2. Yu Z, Pestell TG, Lisanti MP and Pestell RG: Cancer stem cells. Int J Biochem Cell Biol 44: 2144-2151, 2012.
3. Neumüller RA and Knoblich JA: Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer. Genes Dev 23: 2675-2699, 2009.
4. La Porta CA: Mechanism of drug sensitivity and resistance in melanoma. Curr Cancer Drug Targets 9: 391-397, 2009.
5. Yin G, Alvero AB, Craveiro V, Holmberg JC, Fu HH, Montagna MK, Yang Y, Chefetz-Menaker I, Nuti S, Rossi M, Silasi DA, Rutherford T and Mor G: Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential. Oncogene 32: 39-49, 2013.
6. Hurt EM, Chan K, Serrat MA, Thomas SB, Veenstra TD and Farrar WL: Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. Stem Cells 28: 390-398, 2010.
7. Robertson FM, Ogasawara MA, Ye Z, Chu K, Pickei R, Debeb BG, Woodward WA, Hittelman WN, Cristofanilli M and Barsky SH: Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype. J Biomol Screen 15: 820-829, 2010.
8. Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D and Eccles SA: Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 10: 29, 2012.
9. Ayla S, Bilir A, Soner BC, Yilmaz-Dilsiz O, Ergüven M and Oktem G: Notch signaling-related therapeutic strategies with novel drugs in neuroblastoma spheroids. J Pediatr Hematol Oncol 36: 37-44, 2014.
10. Diaz JA and Murillo MF: Phenotype characterization of embryoid body structures generated by a crystal comet effect tail in an intercellular cancer collision scenario. Cancer Manag Res 4: 9-21, 2012.
11. Gaedtke L, Thoenes L, Culmsee C, Mayer B and Wagner E: Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells. J Proteome Res 6: 4111-4118, 2007. (Pubitemid 350158489)
12. + breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785, 2006.
13. Oktem G, Bilir A, Ayla S, Yavasoglu A, Goksel G, Saydam G and Uysal A: Role of intercellular communications in breast cancer multicellular tumor spheroids after chemotherapy. Oncol Res 16: 225-233, 2006. (Pubitemid 46211726)
14. Oktem G, Bilir A, Selvi N, Yurtseven ME, Vatansever S, Ates U, Uysal A and Omay SB: Chemotherapy influences inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) activity on 3D breast cancer cell line. Oncol Res 16: 195-203, 2006. (Pubitemid 44744178)
15. Edwards IJ: Proteoglycans in prostate cancer. Nat Rev Urol 9: 196-206, 2012.
16. Ricciardelli C, Sakko AJ, Ween MP, Russell DL and Horsfall DJ: The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev 28: 233-245, 2009.
17. Sakko AJ, Ricciardelli C, Mayne K, Suwiwat S, LeBaron RG, Marshall VR, Tilley WD and Horsfall DJ: Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res 63: 4786-4791, 2003. (Pubitemid 37022606)
18. Ricciardelli C, Russell DL, Ween MP, Mayne K, Suwiwat S, Byers S, Marshall VR, Tilley WD and Horsfall DJ: Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem 282: 10814-10825, 2007. (Pubitemid 47093429)
19. Ween MP, Hummitzsch K, Rodgers RJ, Oehler MK and Ricciardelli C: Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Clin Exp Metastasis 28: 113-125, 2011.
20. Sakko AJ, Ricciardelli C, Mayne K, Tilley WD, Lebaron RG and Horsfall DJ: Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor β1. Cancer Res 61: 926-930, 2001. (Pubitemid 32174405)
21. Cross NA, Chandrasekharan S, Jokonya N, Fowles A, Hamdy FC, Buttle DJ and Eaton CL: The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFβ1 in prostate cells: relevance to the accumulation of versican. Prostate 63: 269-275, 2005. (Pubitemid 40571061)
22. Knaup J, Gruber C, Krammer B, Ziegler V, Bauer J and Verwanger T: TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa. Anal Cell Pathol 34: 339-353, 2011.
23. Ryynänen M, Knowlton RG, Parente MG, Chung LC, Chu ML and Uitto J: Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa. Am J Hum Genet 49: 797-803, 1991. (Pubitemid 21891726)
24. Switala-Jelen K, Dabrowska K, Opolski A, Lipinska L, Nowaczyk M and Gorski A: The biological functions of β3 integrins. Folia Biol 50: 143-152, 2004.
25. Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100, 2002. (Pubitemid 37328796)
26. Hieken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L and Das Gupta TK: β3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 63: 169-173, 1996. (Pubitemid 26197726)
27. Vacca A, Ria R, Presta M, Ribatti D, Iurlaro M, Merchionne F, Tanghetti E and Dammacco F: αvβ3 integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. Exp Hematol 29: 993-1003, 2001. (Pubitemid 32725797)
28. Rentala S, Yalavarthy PD and Mangamoori LN: α1 and β1 integrins enhance the homing and differentiation of cultured prostate cancer stem cells. Asian J Androl 12: 548-555, 2010.
29. Sagar BM, Rentala S, Gopal PN, Sharma S and Mukhopadhyay A: Fibronectin and laminin enhance engraftibility of cultured hematopoietic stem cells. Biochem Biophys Res Commun 350: 1000-1005, 2006. (Pubitemid 44584192)
30. Lo PK, Kanojia D, Liu X, Singh UP, Berger FG, Wang Q and Chen H: CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene 31: 2614-2626, 2012.
31. Pytliak M, Vargová V and Mechírová V: Matrix metalloproteinases and their role in oncogenesis: a review. Onkologie 35: 49-53, 2012.
32. Inoue A, Takahashi H, Harada H, Kohno S, Ohue S, Kobayashi K, Yano H, Tanaka J and Ohnishi T: Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity. Int J Oncol 37: 1121-1131, 2010.
33. Barami K: Relationship of neural stem cells with their vascular niche: implications in the malignant progression of gliomas. J Clin Neurosci 15: 1193-1197, 2008.
34. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A and Gilbertson RJ: A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82, 2007. (Pubitemid 46054518)
35. Astarci E, Erson-Bensan AE and Banerjee S: Matrix metalloprotease 16 expression is downregulated by microRNA-146a in spontaneously differentiating Caco-2 cells. Dev Growth Differ 54: 216-226, 2012.